Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 1,992,371 | 559,105 | 429,711 | 499,202 | 2,061,819 |
| Cost of Goods | 993,237 | 324,012 | 196,897 | 253,296 | 1,046,824 |
| Gross Profit | 999,134 | 235,093 | 232,814 | 245,906 | 1,014,995 |
| Operating Expenses | 980,689 | 242,947 | 241,833 | 242,404 | 1,059,814 |
| Operating Income | 18,682 | -7,854 | -9,019 | 3,502 | -43,995 |
| Interest Expense | 14,087 | 3,181 | 3,232 | 3,898 | 15,887 |
| Other Income | 431 | 119 | 75 | 96 | 3,026 |
| Pre-tax Income | 5,026 | -10,916 | -12,176 | -300 | -56,856 |
| Income Tax | 7,043 | 2,238 | 814 | 1,611 | -2,874 |
| Net Income Continuous | -2,017 | -13,154 | -12,990 | -1,911 | -53,982 |
| Net Income | $-2,017 | $-13,154 | $-12,990 | $-1,911 | $-53,982 |
| EBITDA(a) | $18,682 | $-7,854 | $-9,019 | $3,502 | $-43,995 |